Cost of treating advanced colorectal cancer: A retrospective comparison of treatment regimens

European Journal of Cancer Part A

Volumn 32, Issue SUPPL. 5, 1996, Pages

  Ross, P ^a   Heron, J ^b   Cunningham, D ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b Diagnosis Healthcare Consulting Ltd   (United Kingdom)

Author keywords

5 fluorouracil; advanced colorectal cancer; health economics; raltritrexed

Indexed keywords

FLUOROURACIL; RALTITREXED;

COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0029959661     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00334-6     Document Type: Conference Paper

References (15)

1. Boring CC, Squires TS, Tong T, et al. Cancer statistics, 1994. CA Cancer J Clin 1994, 44, 7-26.
2. Willet CG, Tepper JE, Cohen AM, et al. Failure patterns following curative resection of colonic carcinoma. Ann Surg 1984, 200, 685-690.
3. Levitan N. Chemotherapy in colorectal carcinoma. Surg Clin North Am 1993, 73, 183-198.
4. Lokich JJ, Ahlgren JD, Gullo JJ, et al. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program study. J Clin Oncol 1989, 7, 425-432.
5. Petrelli N, Herrera L, Rustum Y, et al. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. J Clin Oncol 1987, 5, 1559-1565.
6. Kemeny NE, Conti JA, Bertino JR. Chemotherapy for colorectal cancer. N Engl J Med 1994, 331, 680-681.
7. Poon MA, O'Connell MJ, Moertel CG, et al. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 1989, 7, 1407-1418.
8. Buroker TR, O'Connell MJ, Wieand HS, et al. Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. J Clin Oncol 1994, 12 (1), 14-20.
9. Glimelius B, Hoffman K, Graf W, et al. Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol 1995, 6, 267-74.
10. Cunningham D, Zalcberg JR, Rath U, et al. 'Tomudex' (ZD1694), a new and effective therapy for advanced colorectal cancer has a significantly lower incidence of severe mucositis and leucopenia than standard therapy: results of an open, randomised multicentre trial of 'Tomudex' versus 5-fluorouracil (5-FU) and leucovorin (LV). Eur J Cancer 1995, 31A, (12), 1945-1954.
11. Herrmann R. Systemic treatment of colorectal cancer. Eur J Cancer 1993, 29A, 583-86.
12. MacDonald JS. Continuous low-dose infusion of fluorouracil: is the benefit worth the cost? J Clin Oncol 1989, 7, 412-414.
13. British National Formulary. September edition. London, British Medical Association and Pharmaceutical Press, 1994.
14. Office of Health Economics. Compendium of Health Statistics, 9th edition, 1995.
15. Gardner MJ, Altman DG. Statistics with Confidence - Confidence Intervals and Statistical Guidelines. The Universities Press, Belfast, British Medical Journal, 1989, 72-73.